Alnylam Pharmaceuticals, Inc.
—- Market cap
- —
- Debt
- +$4.12B
- Cash
- −$1.66B
Complete market value, debt and cash evidence is required for enterprise value.
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ALNY · price snapshot
—Price unavailable
Implied fair value · at PENN's multiple
—
Needs PENN P/E.
PENN · price snapshot
—Price unavailable
Implied fair value · at ALNY's multiple
—
Needs Annual EPS is negative, ALNY P/E.
Metric by metric